Chp1 is a dedicated chaperone at the ribosome that safeguards eEF1A biogenesisShow others and affiliations
2024 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 15, no 1, article id 1382Article in journal (Refereed) Published
Abstract [en]
Cotranslational protein folding depends on general chaperones that engage highly diverse nascent chains at the ribosomes. Here we discover a dedicated ribosome-associated chaperone, Chp1, that rewires the cotranslational folding machinery to assist in the challenging biogenesis of abundantly expressed eukaryotic translation elongation factor 1A (eEF1A). Our results indicate that during eEF1A synthesis, Chp1 is recruited to the ribosome with the help of the nascent polypeptide-associated complex (NAC), where it safeguards eEF1A biogenesis. Aberrant eEF1A production in the absence of Chp1 triggers instant proteolysis, widespread protein aggregation, activation of Hsf1 stress transcription and compromises cellular fitness. The expression of pathogenic eEF1A2 variants linked to epileptic-dyskinetic encephalopathy is protected by Chp1. Thus, eEF1A is a difficult-to-fold protein that necessitates a biogenesis pathway starting with dedicated folding factor Chp1 at the ribosome to protect the eukaryotic cell from proteostasis collapse.
Place, publisher, year, edition, pages
Nature Publishing Group, 2024. Vol. 15, no 1, article id 1382
National Category
Biochemistry Molecular Biology Cell and Molecular Biology
Identifiers
URN: urn:nbn:se:umu:diva-221537DOI: 10.1038/s41467-024-45645-wISI: 001255007500001PubMedID: 38360885Scopus ID: 2-s2.0-85185236115OAI: oai:DiVA.org:umu-221537DiVA, id: diva2:1844990
Funder
Knut and Alice Wallenberg Foundation, 2020-0037EU, European Research Council, 743118EU, European Research Council, 101072047European Regional Development Fund (ERDF)Swedish Research Council, 2019-04052Swedish Research Council, 2023-04717Swedish Research Council, 2017- 03783Swedish Research Council, 2021-01146Swedish Cancer Society, 20 1045Swedish Cancer Society, 23 2949Swedish Cancer Society, 20 0872German Research Foundation (DFG), DFG KR 3593/4-12024-03-152024-03-152025-04-24Bibliographically approved